A Comparative Study of Surgical Approaches for Hepatocellular Carcinoma: Conversion versus Direct Resection
Xinlin Li,Kai Chen,Xu Feng,Xinhua Wu,Shiguai Qi,Qingmiao Wang,Zhengrong Shi
DOI: https://doi.org/10.2147/jhc.s483397
2024-10-30
Journal of Hepatocellular Carcinoma
Abstract:Xinlin Li, 1 Kai Chen, 1 Xu Feng, 1 Xinhua Wu, 1 Shiguai Qi, 1 Qingmiao Wang, 2 Zhengrong Shi 1 1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, People's Republic of China; 2 Department of Obstetrics and Gynecology, The Fifth People's Hospital of Chongqing, Chongqing, Chongqing, People's Republic of China Correspondence: Zhengrong Shi, Email Purpose: The purpose of This study is exploring the intraoperative and perioperative differences between patients undergoing conversion surgery and those undergoing direct surgery, so as to improve preoperative preparation. Methods: The retrospective study was approved by an ethics review committee. A total of 232 patients with hepatocellular carcinoma who underwent surgical resection at the First Affiliated Hospital of Chongqing Medical University from September 2022 to December 2023 were included, comprising 210 operating patients and 53 conversion patients. Propensity score matching was employed for comparison in order to minimize bias. Results: The conversion group had more intraoperative bleeding (each P=0.001), longer operation time (P=0.033; PSM p=0.025), and higher intraoperative blood transfusion rate (p=0.001; PSM p=0.044). The incidence of perioperative complications, including perioperative ascites formation (p=0.011; PSM p=0.005), moderate to severe anemia (p=0.001; PSM p=0.002), postoperative blood transfusion (p=0.004; PSM p=0.036), and postoperative ICU transfer (p=0.041; PSM p=0.025), was higher in the conversion group compared to the operation group. The postoperative hospital stay (p=0.001; PSM p=0.003) was prolonged in the conversion group. Conclusion: Post-conversion operations carry a higher risk of bleeding and are more likely to result in moderate to severe anemia and ascites formation in the perioperative period. However, the risk is reversible with adequate preoperative blood preparation and prompt postoperative symptomatic treatment. Conversion patients should be encouraged to undergo operating therapy when they can withstand surgical resection. Keywords: conversion therapy, hepatocellular carcinoma, perioperative complications, hepatectomy, perioperative complications Hepatocellular carcinoma is currently the third leading cause of cancer death. 1 Surgical resection is currently the most effective radical treatment for hepatocellular carcinoma, but due to the lack of typical symptoms in the early stage, many patients have lost the opportunity to radical resection of hepatocellular carcinoma. 2 Conversion therapy refers to the opportunity for hepatocellular carcinoma patients who are not suitable for surgical resection to obtain surgical resection after intervention, which mainly includes functional future liver remnant volume (FLR) transformation and oncology transformation. Currently, palliative treatment programs such as drugs or TACE are commonly used to reduce tumor stage as much as possible. 3 To provide inoperable patients with the opportunity to undergo radical resection. In recent years, with the development of immunotherapy and chemotherapy drugs, the therapeutic effect of unresectable hepatocellular carcinoma has made significant progress, which also makes the conversion rate of unresectable has been significantly improved, and more and more patients have access to the opportunity of radical resection. 4 Surgical resection represents a significant means for the long-term survival of patients patients after transformation. Several pieces of research evidence suggest that patients who undergo radical resection subsequent to palliative care often witness an enhanced overall survival rate. 5 For patients who have undergone transformative treatment, there is no explicit standard for the timing of surgical intervention. Presently, the decision to conduct radical surgery and the choice of surgical method largely hinge on the clinical judgment of the surgeon. However, there exists a deterministic disparity in the hepatic status of patients post-transformative treatment compared to the general population, notwithstanding the potential absence of significant differences in preoperative assessments such as liver function, routine blood tests, and coagulation function. Research indicates that the success rate of transformation is higher when combining interventional treatments (TACE/HAIC) with targeted or immunotherapies, compared to standalone treatments. 6 In our institution, a combined approach incorporating interventional treatments along with targeted or immunotherapies is uniformly employed for patients with advanced hepatocellular -Abstract Truncated-
oncology